Prognostic Role of Adaptive Immune Microenvironment in Patients with High-Risk Myelodysplastic Syndromes Treated with 5-Azacytidine.Published in:Cancers, 2025, v. 17, n. 7, p. 1104, doi. 10.3390/cancers17071104By:Tsakiraki, Zoi;Spathis, Aris;Bouchla, Anthi;Pouliakis, Abraham;Vryttia, Pinelopi;Panayiotides, Ioannis G.;Pappa, Vasiliki;Papageorgiou, Sotiris G.;Foukas, Periklis G.Publication type:Article